1. Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea. Issue 3 (6th March 2020) Authors: Lembo, Anthony; Rao, Satish S. C.; Heimanson, Zeev; Pimentel, Mark Journal: Clinical and translational gastroenterology Issue: Volume 11:Issue 3(2020) Page Start: e00144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessing the Efficacy of Rifaximin in Diarrhea‐Predominant Irritable Syndrome (IBS‐D): A Post hoc Analysis of 2 Phase 3, Randomized, Placebo‐Controlled Trials: 482. (October 2017) Authors: Pimentel, Mark; Cash, Brooks D.; Lacy, Brian E.; Heimanson, Zeev; Lembo, Anthony J. Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of Potential Impact of Demographic and Baseline Disease Characteristics on Rifaximin Monotherapy versus Lactulose Combination Therapy for the Prevention of Overt Hepatic Encephalopathy (OHE) Recurrence: 875. (October 2017) Authors: Flamm, Steven; Mullen, Kevin; Heimanson, Zeev; Sanyal, Arun Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States. (1st January 2021) Authors: Volk, Michael L.; Burne, Rebecca; Guérin, Annie; Shi, Sherry; Joseph, George J.; Heimanson, Zeev; Ahmad, Maliha Journal: Journal of medical economics Issue: Volume 24:Number 1(2021) Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of Colonoscopy Timing on Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea (IBS‐D): 506. (October 2019) Authors: Lacy, Brian E.; Lembo, Anthony; Pimental, Mark; Heimanson, Zeev; Cash, Brooks D. Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea. (December 2019) Authors: Rezaie, Ali; Heimanson, Zeev; McCallum, Richard; Pimentel, Mark Journal: American journal of gastroenterology Issue: Volume 114:Number 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lactulose Breath Testing Predicts the Response to Rifaximin: 423. (October 2017) Authors: Rezaie, Ali; Heimanson, Zeev; Israel, Robert; Pimentel, Mark Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P148 LACK OF INFLUENCE OF ELDERLY AGE AND GENDER ON THE SAFETY PROFILE OF BUDESONIDE EXTENDED-RELEASE TABLETS FOR ULCERATIVE COLITIS: A POOLED ANALYSIS OF TWO RANDOMIZED, DOUBLE-BLIND, PHASE 3 TRIALS. (18th January 2018) Authors: Lichtenstein, Gary R; Heimanson, Zeev; Bosworth, Brian P Journal: Inflammatory bowel diseases Issue: Volume 24(2018)Supplement 1 Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial. (September 2017) Authors: Cash, Brooks D.; Pimentel, Mark; Rao, Satish S. C.; Weinstock, Leonard; Chang, Lin; Heimanson, Zeev; Lembo, Anthony Journal: Therapeutic advances in gastroenterology Issue: Volume 10:Number 9(2017) Page Start: 689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Responders Analysis in Patients With Diarrhea‐Predominant Irritable Bowel Syndrome (IBS‐D) Treated With Rifaximin: 444. (October 2017) Authors: Lembo, Anthony J.; Heimanson, Zeev; Pimentel, Mark Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗